
Gaudium IVF to List on Stock Exchange Today: Market Experts Anticipate Cautious Trading Debut
Gaudium IVF & Women Health Ltd IPO Listing
Date: 27 February 2026 Exchange: BSE and NSE
The equity shares of Gaudium IVF & Women Health Ltd will be listed in the Indian stock market today, following a strong demand for its initial public offering (IPO). The public issue was open for public subscription from February 20 to 24, with the IPO allotment date being February 25.
The company's shares will be listed on both the BSE and NSE, with trading members informed that the shares will be in the Trade-for-Trade segment for 10 trading days. Additionally, the shares will be part of the Special Pre-open Session (SPOS) on Friday, February 27, 2026, and will be available for trading from 10:00 AM.
Read also: SMR Jewels IPO Successfully Lists with Institutional Support
Ahead of the listing, investors are watching trends in the grey market premium (GMP) to gauge the estimated listing price. The current Gaudium IVF IPO GMP is ₹0 per share, indicating that the shares are trading equal to their issue price of ₹79 per share. Analysts expect a muted listing of shares.
Key IPO Details:
- Issue Price: ₹75 to ₹79 per share
- Fresh Issue: 1.14 crore equity shares worth ₹90 crore
- Offer-for-Sale (OFS): 94.93 lakh shares amounting to ₹75 crore
- Total Issue Size: ₹165 crore
- Subscription Status: Subscribed 7.27 times in total, with 7.60 times subscription in the Retail Individual Investors category and 14.05 times subscription in the Non Institutional Investors segment.
The book running lead manager for the IPO is Sarthi Capital Advisors Pvt. Ltd., and the registrar is Bigshare Services Pvt. Ltd.
Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO
Investor Takeaway
Investors should be cautious during Gaudium IVF's trading debut due to potential volatility.
More in IPO

SMR Jewels IPO Successfully Lists with Institutional Support

Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Merritronix IPO Sees Robust Subscription, Oversubscribed by 293 Times on Final Day
